FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

3328911000001103: Carbocisteine 250mg/5ml oral solution 300 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22362901000001116 Carbocisteine 250mg/5ml oral solution 300 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22363001000001113 Carbocisteine 250mg/5ml oral solution 300 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

14 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbocisteine 250mg/5ml oral solution 300 ml Has VMP Carbocisteine 250mg/5ml oral solution true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution 300 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution 300 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution 300 ml Is pack of Carbocysteine 250mg/5mL syrup false Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution 300 ml Has active ingredient Carbocisteine false Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution 300 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution 300 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution 300 ml Has manufactured dose form Conventional release oral syrup false Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution 300 ml Has VMP Carbocysteine 250mg/5mL syrup false Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution 300 ml Has specific active ingredient Carbocisteine true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution 300 ml Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution 300 ml Has VMP Carbocisteine 250mg/5ml oral solution false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Carbocisteine 250mg/5ml oral solution (DE Pharmaceuticals) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier
Mucodyne 250mg/5ml syrup (Beacon Pharmaceuticals Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Teva UK Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Brown & Burk UK Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (NorthStar Healthcare Unlimited Company) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Medihealth (Northern) Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier
Mucodyne 250mg/5ml syrup (Lexon (UK) Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier
Mucodyne 250mg/5ml syrup (Mawdsley-Brooks & Company Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier
Mucodyne 250mg/5ml syrup (Sigma Pharmaceuticals Plc) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier
Mucodyne 250mg/5ml syrup (Doncaster Pharmaceuticals Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Accord Healthcare Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (A A H Pharmaceuticals Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Alliance Healthcare (Distribution) Ltd) 300 ml Is a True Carbocisteine 250mg/5ml oral solution 300 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start